Real Madrid have named their squad for the game against Celta on matchday 15 of LaLiga, which will be played at the Bernabéu (Sunday, 9 pm CET).
REAL MADRID SQUAD:
Goalkeepers: Courtois, Lunin, Mestre.
Defenders: Militão, Asencio, Á….

Real Madrid have named their squad for the game against Celta on matchday 15 of LaLiga, which will be played at the Bernabéu (Sunday, 9 pm CET).
REAL MADRID SQUAD:
Goalkeepers: Courtois, Lunin, Mestre.
Defenders: Militão, Asencio, Á….

Netflix and Warner Bros. Discovery‘s blockbuster deal announcement early Friday sent a shock wave through the industry. The streamer outbid Paramount and Comcast for Warner Bros. studios and HBO/HBO Max in a deal valued at $82.7 billion,…

Jonathan HolmesWest of England
BBCTwo hospitals are asking people to wear face masks amid rising flu cases.
Salisbury District and Great Western Hospitals in…

Researchers at the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have uncovered a previously unrecognized organizational pattern in one of the brain’s key regions for learning and…

Researchers at the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have uncovered a previously unrecognized organizational pattern in one of the brain’s key regions for learning and…


Item 1 of 2 Tourists gather at the General Wolfe Statue viewpoint overlooking Canary Wharf, in Greenwich Park, London, Britain, September 30, 2025. REUTERS/Corey Rudy
The German bank will take about twice as much space in the YY building on South Colonnade as Revolut, the report said, citing people familiar with the matter.
Sign up here.
Deutsche Bank declined to comment on the report. Canary Wharf Group referred Reuters to asset manager Oaktree Capital Management, which owns the building, when asked for a comment. Oaktree declined to comment.
Oaktree bought the building in a joint venture with real estate firm Quadrant Estates in 2019, according to Quadrant’s website. Quadrant could not be reached for comment.
($1 = 0.7502 pounds)
Reporting by Angela Christy and Gnaneshwar Rajan in Bengaluru; Editing by Sam Holmes, William Mallard and Barbara Lewis
Our Standards: The Thomson Reuters Trust Principles.

Since September, Senegal has been facing an outbreak of Rift Valley Fever (RVF), a viral disease transmitted by mosquitoes or through contact with infected animals.
As of December 3, three months after the outbreak was declared, the Senegal…

Accenture (ACN) has been grinding higher recently, with the stock up about 7% over the past month despite a rough year for shareholders. That move has investors rechecking whether today’s price still lines up with fundamentals.
See our latest analysis for Accenture.
The recent rebound follows a tough stretch, with a negative year to date share price return and a roughly 12 month total shareholder return still in the red. This hints that sentiment is improving but not fully repaired.
If Accenture has you rethinking your tech exposure, this could be a good moment to explore high growth tech and AI stocks for other potential opportunities riding similar digital transformation themes.
With earnings still growing and the share price lagging its recent peak, investors now face a key question: is Accenture quietly offering value at today’s levels, or is the market already pricing in its next leg of growth?
According to FCruz, the narrative implies a fair value well below Accenture’s last close of $266.59, setting up a tension between quality and price.
Bottom line (fundamental stance) I’m moderately constructive over 12 to 18 months. Accenture combines (i) scaled exposure to GenAI-led reinvention with tangible bookings, (ii) high-quality margins, returns, and FCF, and (iii) a reset valuation near historical norms. The near-term swing factor is bookings momentum; if that stabilizes or improves, upside to the Street’s mid-30s EPS multiple case becomes more plausible.
Read the complete narrative.
Want to see how modest revenue growth, steady margins and a premium future earnings multiple still argue for a much lower fair value than today? The full narrative walks through those moving parts step by step, but keeps one core valuation lever front and center. Curious which assumption does most of the heavy lifting, and how sensitive the outcome is if it shifts?
Result: Fair Value of $202.38 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, persistent weakness in bookings or a sharper slowdown in consulting spend could quickly challenge the case for Accenture’s current premium valuation.
Find out about the key risks to this Accenture narrative.
While the most popular narrative sees Accenture as roughly 31.7% overvalued, our valuation work using a simple earnings multiple lands in a different place. At 21.5 times earnings, the stock trades well below the US IT industry average of 30.3 times and peers at 25.3 times, and also below a fair ratio of 36.7 times that the market could drift toward over time.

Wondering if First Quantum Minerals is still good value after its big run, or if you are late to the party? This breakdown will help you decide whether the current price makes sense or is getting ahead of itself.
The stock has climbed 4.6% over the last week, 16.8% over the past month, and 76.0% year to date, with a 63.4% gain over the past year that has clearly caught the market’s attention.
Much of this move has been driven by shifting sentiment around copper prices and expectations for long term supply constraints, as investors increasingly treat copper exposed miners as leveraged plays on the energy transition. On top of that, headlines around First Quantum’s asset mix, project pipeline, and jurisdictional risks have kept the stock in the spotlight and added volatility to how investors are pricing its future cash flows.
Despite the rally, First Quantum Minerals currently scores 5 out of 6 on our valuation checks, suggesting it still screens as undervalued on most metrics. Next, we will dig into those different valuation approaches, before finishing with a more holistic way to think about what the stock is really worth.
Find out why First Quantum Minerals’s 63.4% return over the last year is lagging behind its peers.
The Discounted Cash Flow model estimates what a business is worth by projecting the cash it could generate in the future and then discounting those cash flows back to today in dollar terms. For First Quantum Minerals, the 2 Stage Free Cash Flow to Equity model starts from last twelve month free cash flow of about $1.5 billion, and then applies analyst forecasts for the next few years before extrapolating longer term trends.
Analysts and model estimates see free cash flow rising to roughly $4.0 billion by 2029, with detailed projections stepping up from the low hundreds of millions in 2026 into the multi billion range later in the decade as new projects and higher copper volumes are factored in. Simply Wall St then extends these growth patterns into the following years to capture a full value for the business.
Bringing all of those cash flows back to today, the DCF fair value is estimated at $93.10 per share. That implies the shares trade at about a 64.2% discount to intrinsic value, which suggests material upside if these cash flow assumptions prove broadly correct.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests First Quantum Minerals is undervalued by 64.2%. Track this in your watchlist or portfolio, or discover 906 more undervalued stocks based on cash flows.